TG Therapeutics, Inc. (NASDAQ: TGTX), today announced it ranked number 27 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...

Sandoz Group Ltd ( ($CH:SDZ) ) has provided an announcement. Sandoz has launched TYRUKO® (natalizumab-sztn), the first and only FDA-approved ...

He has been on the FBI’s Ten Most Wanted list since March. Read more at straitstimes.com. Read more at straitstimes.com.

Twenty people, including 14 law enforcement officers, have pleaded not guilty to federal charges in a Mississippi Delta drug ...

When your body's immune cells attack you instead of protecting you, today's treatments tamp down the friendly fire but they ...

Unequal global access to inflammatory bowel disease (IBD) therapies creates profound health inequities. The increasing prevalence of IBD in Western countries, driven by high incidence rates and low ...

A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer’s disease.

In the third quarter, lower sales of Biogen’s multiple sclerosis (“MS”) drugs are likely to have been offset by sequential revenue growth from new products. Sales of Biogen’s MS drugs like Tecfidera ...